主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA

Archive

  • Select all
    |
    Perspectives & Review
  • Perspectives & Review
    DONG Zihao, WU Wenzhe
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Dry powder inhalers(DPIs) have the advantages of avoiding the first-pass effect, high bioavailability, ease of administration and so on. However, due to high variability of powder characteristics, it is difficult to achieve accurate delivery of inhalable dosage. Moreover, as a formulation-device combination delivery system, formulation and device design also need to be considered. The implementation of quality by design(QbD) tools, including risk assessment, design of experiment(DoE), process analytical technology(PAT), and predictive science, can effectively reduce the variability of powder characteristics, increase lung deposition and ultimately improve the quality of life of patients. And at the same time, researchers are supposed to have the ability to consider the pulmonary delivery efficiency of inhalable dry powder from a statistical perspective. This paper reviews the advantages of application of the QbD concept and tools in the development of DPIs, expecting to provide some references for future product development.
  • Perspectives & Review
    GUO Mingqing, LIAO Zongquan, SHI Ying, CHEN Yongsheng, ZHOU Haifeng
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Esketamine, a single isomer of the anesthetic drug ketamine, has been marketed as an antidepressant. Its asymmetric synthesis has become a research focus for synthetic chemists in recent years. In this review, three strategies including asymmetric rearrangement, asymmetric amination and asymmetric difunctionalization of alkene for the synthesis of esketamine have been summarized, which will be benefit to the researchers engaged in asymmetric synthesis of esketamine.
  • Perspectives & Review
    SONG Shuo, QIAN Yimin, WANG Ruonan, HONG Min, LI Hua
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Bispecific antibody(bsAb) is an artificial antibody based on the structural modification of monoclonal antibody, which can specifically bind two different antigens or epitopes at the same time, and block its mediated biological functions or make the cells expressing the two antigens get close to each other to enhance the interaction between them. In terms of recruiting immune cells, fighting bacterial or viral infections, Alzheimer's disease and regenerative medicine, bsAb has shown advantages that monoclonal antibodies and even monoclonal antibody combinations cannot match. With the application of genetic engineering and protein engineering in the construction of bsAb formats, the technology platform, design concept and variety research and development of bsAb formats are constantly innovated. The formats of bsAb were divided into fragment-based formats and complete antibody-based formats. This paper mainly introduces the mechanisms of action of bsAb from three aspects, which are redirecting cytotoxic active effector cells, blocking the formation of multiple pathways, proteins or neovascularization and mediating the formation of protein complexes.
  • Perspectives & Review
    LI Linghui, TU Yingying, ZHAO Xinyu, JIANG Shuguang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    At present, improving solubility and dissolution rate of poorly soluble drugs by pharmaceutical techniques is one of the research hotspots of oral delivery of biopharmaceutical classification system(BCS) class Ⅱ compounds. As a novel solid preparation technology that can provide a reliable and robust drug product manufacturing, hot melt extrusion(HME) has been widely used in preparation of polymeric amorphous solid dispersion, continuous melt granulation, and so on. However, polymers are relatively limited in HME until now. Furthermore, the complex rheological behaviors of polymer melts and their interactions with drugs generally affect the extrusion processability and dissolution behavior. This review focuses on polymer carriers used in HME process for improving dissolution of poorly soluble drugs, and reviews the research progress of related extrusion theories, applicable polymers, the interactions between polymer carriers and drugs, and rheological properties of melt during extrusion.
  • Paper
  • Paper
    ZHOU Lixin, PENG Jiajuan, JIA Zhongtian, ZHU Xueyan, ZHANG Peng
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In this report, the synthetic process of baloxavir marboxil, a novel anti-influenza virus drug, was improved. 3-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid(6) was synthesized from methylmaltol(2) by benzylation, aldol condensation and oxidation. Compound 6 was converted to methyl 3-benzyloxy-1-[(tert-butoxycarbonyl)amino]- 4-oxo-1,4-dihydropyridine-2-carboxylate monohydrate(8) by esterification, and hydrazinolysis. Compound 8 was subjected to condensation with 2-(2,2-dimethoxyethoxy)ethan-1-amine(9) followed by cyclization and chiral resolution to give (R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione(13). Compound 13 was subjected to protecting group exchange and then reacted with 7,8-difluoro-6,11-dihydrodibenzo[b,e]- thiepin-11-ol(15) to afford (R)-12-[(S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-hexyloxy-3,4,12,12atetrahydro- 1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione methanesulfonate(16). Compound 16 was hydrolyzed in the presence of lithium chloride, and then reacted with chloromethyl carbonate to afford 1 with a purity of 99.09%, with de of 99.88% and ee of 99.99%. During preparation of 6, the feeding mode was changed and sulfamic acid and sodium chlorite instead of sodium hypochlorite were used as the oxidants, which could not only shorten the reaction time, but also increased the yield from 36% to 70%. In the preparation of tert-butyl[3-benzyloxy-2-[[2-(2,2- dimethoxyethoxy)ethyl]carbamoyl]-1,4-dihydro-4-oxopyridin-1-yl]carbamate(10), the cost of 9 could be reduced via a sealed reaction condition. This improved process has mild reaction conditions and simple work-up, with a total yield of 8%(based on 2).
  • Paper
    HE Chasheng, ZHAI Ziran, ZHOU Yang, WANG Guan
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The synthetic process of lopinavir(1) was improved in this reported. Tert-butyl[(1S,3S,4S)-4- amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamate(2) reacted with 2,6-dimethylphenoxyacetic acid(3) in the presence of O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate(HBTU) and trimethylamine to give (2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(tert-butoxycarbonyl)amino- 1,6-diphenylhexane(4). And then N-[(1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6- dimethylphenoxy)acetamide(5) was prepared by deprotecting N-Boc from 4 with trifluoroacetic acid. Compound 5 was condensed with (2S)-(1-tetrahydropyrimidine-2-one)-3-methylbutyric acid(6) to obtain 1 in a total yield of 63%(based on 2). This improved process was easy to operate and the product quality was stable and controllable. The expensive raw materials 3 and 6, which had no commercial supply in China, were also prepared, and it could provide a reference for lowcost preparation of 1.
  • Paper
    YU Liguo, SUN Guangxiang, ZHANG Yunran, ZHU Yijun, WANG Bing
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In this report, N-(tert-butoxycarbonyl)-D-aminoprohydroxamic acid(3) was obtained by condensation from N-(tert-butoxycarbonyl)-D-alanine(2). Then, compound 3 reacted with cyclopentadiene to give [(R)-1-[(1S,4R)-2-oxa-3-azabicyclo[2.2.1]hept-5-en-3-yl]-1-oxopropan-2-yl]tert-butyl carbamate(4) via oxidation and Diels-Alder reaction. Then [(R)-1-[(1S,4R)-2-oxa-3-azabicyclo[2.2.1]hept-3-yl]-1-oxopropan-2-yl]tert-butyl carbamate(5) was obtained by catalytic hydrogenation. And the key intermediate of bictegravir, (1R,3S)-3- aminocyclopentanol hydrochloride(1) was obtained by hydrolysis, Boc protection, catalytic hydrogenation, and deprotection, with a total yield of 43%, a purity of 99.65%, and ee value of 99.74%. Compound 5 has not been found in the literature before, nor the route from 5 to tert-butyl[(1S,3R)-3-hydroxycyclopentyl]carbamate(7). Compound 2 had a good induction effect on Diels-Alder reaction, achieving asymmetric synthesis. The reaction conditions are mild, avoiding the use of inflammable, explosive and other dangerous reagents.
  • Paper
    JIA Shu, ZHANG Congcong, WANG Shuo, YAO Xiaomin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Ambrisentan(1) is an endothelin-1 receptor antagonist. In this paper, a novel synthetic route for 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid(2), the key intermediate of 1, was reported. Ethyl 3,3-diphenylacrylate(4) was obtained from benzophenone(3) with triethyl phosphatoacetate by Wittig-Horner reaction. Ethyl 2-bromo-3-methoxy-3,3-diphenylpropanoate(5) was synthesized by electrophilic addition of 4 with NBS in methanol. Compound 5 was esterified with acetic acid to give ethyl 2-acetoxy-3-methoxy-3,3-diphenylpropanoate(6), and then without separation, 6 was hydrolyzed directly to obtain 2 in a total yield of 75%. In this process, the materials are cheap and easily available, and it avoids the Darzens condensation reaction, which is suitable for industrial production.
  • Paper
    RONG Shaofeng, GENG Dongdong, XIAO Gang, XUE Yong, YU Ying, GUAN Shimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    AspergiLLus ochraceus(AspergiLLus) was used as the original strain to produce chitosan by fermentation condition optimization, and three batches of laboratory and pilot plant were carried out in 5 L and 100 L bioreactors to further characterize the structure of microbial chitosan. Through optimization of fermentation conditions, the optimal fermentation medium formula was as follows: glucose 20.0 g/L, peptone 10.0 g/L, corn steep liquor 20.0 g/L, ammonium dihydrogen phosphate 1.0 g/L, and pH 7.0. On the basis of this medium condition, the output of chitosan in the shake flask was 1.98 g/L, the chitosan average output in 3 batches of the 5 L and 100 L bioreactor was 3.26 and 3.97 g/L respectively. In addition, infrared spectroscopy and elemental analysis were performed on microbial chitosan. The infrared spectra showed that the functional groups and chemical shifts of microbial chitosan were consistent with those of the standard. Elemental analysis results showed that the content of nitrogen, carbon and hydrogen in microbial chitosan were 8.43%, 44.87% and 6.65% respectively.
  • Paper
    ZHANG Dongliang, XI Quan, MIAO Jiaying
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Tofacitinib citrate extrudable elementary osmotic pump(EEOP) tablets were prepared in this paper, and the influences of formulation factors on in vitro release of the tablets were investigated with similarity factor(f2) between the different formulations as the index. The results of single factor tests showed that sorbitol amount, coating weight gain, the type and dosage of polymer as well as tablet shape had significant effects on the drug release. The location of drilling orifice at one end of the caplet was helpful to solve the problem of incomplete release of the elementary osmotic pump. The optimized polymer hydroxyethyl cellulose affected not only the process of drug migration out of the tablet core, but also the link of drug diffusion to the release medium, so its amount had dual effects on the drug release rate. In order to deeply understand the influence of polymer properties on drug release of EEOP system, different polymer solutions were characterized by apparent viscosity, elastic modulus, viscous modulus and phase angle so as to construct the relationship between rheological properties of polymer and drug release properties. According to the results, a direct relationship between apparent viscosity alone and drug release performance cannot be established. However, EEOP tablets prepared with the polymer having higher viscous modulus would have a faster drug release rate.
  • Paper
    DONG Xusheng, WANG Peng, CHEN Lan, CHEN Donghao
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The morphology of lactose carrier may influence the blending process and dispersibility of dry powder inhaler(DPI) formulations. In this study, the surface morphology of lactose(InhaLac230?) was modified by storing under high environment humidity environment for 72 h. The modified lactose carrier has smoother surface compared with untreated lactose, but both had similar particle size distribution and the same crystalline form. Two lactose powders were respectively mixed with the micronized chlorpheniramine maleate to obtain the formulation models. The static electricity and blending uniformity of the DPI formulations at different time points during the mixing process were measured and compared. The content of drug separated by the vibration sieving method was determined to evaluate the binding force between the drug and lactose carrier. Meanwhile, the in vitro dispersibility of the DPI formulations were investigated with fast screening impactor(FSI). The results showed that the lactose with smooth surface achieved blend uniformity faster and better. The change of static electricity of powders with time approximately reflected the progress of blending process. However, the binding force of the formulation containing lactose carrier with high humidity treatment was much stronger than that of the non-treatment group, resulting in poorer in vitro dispersion performance. In addition, the drug contents of the blends after sieving had a clear correlation with the in vitro dispersion results.
  • Paper
    LI Xuanzhe, ZHANG Xinxin, YI Pengyan, DING Jinsong
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The correlation between the adsorption of lactose carrier and the powder blending uniformity during the preparation process for low-dose tablets of insoluble drugs by direct compression were explored with olanzapine tablets as the model. The influences of micromorphological features of different grades of lactose carrier, the proportion of lactose carrier in the formulation, the particle size of micronized olanzapine, the mixing method and mixing time on the adsorption of olanzapine by the lactose carrier were investigated by single factor test with powder blending uniformity of the mixture as the index. The results showed that the stable absorption of lactose carrier was achieved when using a ratio of 67% or higher amount of spray-dried lactose carrier with round shapes, micronized olanzapine with d(0.9) no more than 39 μm and mixing for 10 min, which made the coefficient of variation of powder blending uniformity lower than 2%. The content uniformity of three batches of validation tablets complied with the requirements(A+2.4S<6). It was concluded that stabilizing the adsorption of olanzapine by lactose carrier could ensure blending uniformity during the preparation of olanzapine tablets by direct compression.
  • Paper
    HE Hongling, ZHANG Lei, CHEN Tingting, MA Zhimin, LI Qingguo
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Insoluble drug tadalafil was coated on microcrystalline cellulose(MCC) pellet cores to prepare immediate-release pellets by supercritical anti-solvent fluidization(SAS-FB) coating technology in this paper. The morphology and in vitro dissolution of the pellets were compared with those of tadalafil treated with the supercritical antisolvent(SAS) and the pellets prepared by fluidized bed(FB)coating. The scanning electron micrographs of the pellets prepared by SAS-FB showed that tadalafil was uniformly distributed on the surface of the MCC pellet cores in the form of thin strips, while the pellets produced by FB were coated with bulk crystalline tadalafil. The shape of tadalafil treated with SAS was similar to the bulk drug, clustered in thin strips. Comparing with the other two methods, the pellets prepared by SAS-FB had faster in vitro dissolution rate and higher dissolved percentage. By surface modification of MCC cores with sodium dodecyl sulfate or polyvinylpyrrolidone, the dissolution rate and dissolved percentage of tadalafil pellets prepared by SAS-FB could be further improved. This study showed that the SAS-FB could prepare tadalafil pellets in one step, which had the potential to improve the dissolution of poorly soluble drugs.
  • Paper
    WEN Songsong, NIU Chong, LIU Qi, CHEN Zhen, XU Yuwen
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    An gas chromatography-mass spectrometry(GC-MS) was established to determine the genotoxic impurity N-nitrosodimethylamine(NDMA) in metformin hydrochloride and its preparations. The capillary column (0.25 mm×30 m, 0.25 mm) with polyethylene glycol as the stationary phase and an electron impact(EI) ion source were used. The selected reaction monitoring(SRM) mode was adopted. The quantitative ion pair was m/z 74→m/z 44(5 eV), and the qualitative ion pair was m/z 74→m/z 42(15 eV). The results showed that the detection limit of NDMA was 0.15 ng/ml and the quantification limit was 0.5 ng/ml. It was linear for NDMA in the range of 0.25 - 50 ng/ml. The RSDs of the precision, repeatability, and stability tests were all less than 10%, and the average recovery rate was 93.2% - 97.9%. This method has high sensitivity, strong specificity, accurate results and good reproducibility, which is suitable for the determination of the genotoxic impurity NDMA in metformin hydrochloride and its preparations.
  • Paper
    LIANG Bo, ZHENG Ye, WANG Rongjia, ZHANG Fangfang, CAI Rong
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A gas chromatography method was established to determine the cyclohexanone and 2-ethyl-1-hexanol in disposable infusion sets. The HP-INNOWAX column was used with nitrogen as the carrier gas. The flow rate was 2 ml/min, the split ratio was 10∶1, the injection port temperature was 250 ℃, the FID temperature was 270 ℃, and the internal standard was isobutyl alcohol. The results showed that cyclohexanone and 2-ethyl-1-hexanol were linear in the ranges of 0.2 - 15 and 0.02 - 2.0 μg/ml, and the detection limits were 0.01 and 0.02 μg/ml respectively. The sample test results showed that cyclohexanone and 2-ethyl-1-hexanol were detected in some infusion sets. The migration amount was proportional to the instillation time, and the concentration of liquid medicine. This method was accurate, stable, and feasible, which could be used to investigate the migration of cyclohexanone and 2-ethyl-1-hexanol in infusion sets of different injection solution.
  • Paper
    YANG Yang, WU Wenzhe, CHEN Hongyue, DONG Zihao
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    An UFLC-MS/MS method was established to determine the plasma concentration of levodopa in rats. An Phenomenex Gemini C18 column(2.0 mm×100 mm, 5 μm) was used, with the mobile phase A of 0.2% formic acid solution, and the mobile phase B of acetonitrile. The flow rate was 0.3 ml/min, the injection volume was 10 ml, and the column temperature was 40 ℃. The results showed that it was linear for levodopa calibration curve in the range of 100 - 6 000 ng/ml. The lower limit of quantification was 100 ng/ml and the average recovery rate of plasma containing levodopa was 98.87% - 101.34%. The method is specific and precise, which provides a reference for the quantitative analysis of levodopa plasma samples.
  • Paper
    HAO Guizhou, YANG Yong, CUI Xiangzhen, YAO Na, ZHANG Guimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    An HPLC method was established to detect the leachable substances phthalide and phenol in disposable infusion sets. An YMC-Pack Pro C18 column was used, with the mobile phase A of 0.04 mol/L potassium dihydrogen phosphate and 0.2% triethylamine solution∶acetonitrile∶isopropanol(92∶4∶4), and mobile phase B of 0.04 mol/L potassium dihydrogen phosphate and 0.2% triethylamine solution(pH 6.6)∶acetonitrile(40∶60)for gradient elution. The detection wavelength was 220 nm, the column temperature was 40 ℃, the flow rate was 1 ml/min, and the injection volume was 20 μl. The results showed that it was linear for phthalide and phenol in the range of 0.050 - 5.04 and 0.050 - 5.00 μg/ml respectively. The average recoveries of phthalide and phenol were 100.96% and 100.64%, with RSDs(n=9) of 3.70% and 2.41% respectively. The detection limits of phthalide and phenol were both 0.025 μg/ml, and the quantification limits were both 0.050 μg/ml. The sample test results showed that phthalide and phenol were detected in 4 batches of infusion set samples. This method is sensitive and accurate, which can detect phthalide and phenol in disposable infusion sets.
  • Pharmaceutical Management & Information
  • Pharmaceutical Management & Information
    CHEN Chao, WANG Dandan, CHENG Lei, CAI Zhiwei, CHEN Yue
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    YANG Ruiya, LIANG Yi
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    ZHANG Yingming, SUN Yu, FENG Xiaoyun
    Abstract ( ) Download PDF ( )   Knowledge map   Save